{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:45:14Z","timestamp":1790703914749,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T00:00:00Z","timestamp":1389571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T00:00:00Z","timestamp":1389571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Current criteria for early diagnosis of coagulopathy in sepsis are limited. We postulated that coagulopathy is already complicated with sepsis in the initial phase, and severe coagulopathy or disseminated intravascular coagulation (DIC) becomes overt after progressive consumption of platelet and coagulation factors. To determine early diagnostic markers for severe coagulopathy, we evaluated plasma biomarkers for association with subsequent development of overt DIC in patients with sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A single-center, prospective observational study was conducted in an adult ICU at a university hospital. Plasma samples were obtained from patients with sepsis at ICU admission. Fourteen biomarkers including global markers (platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen and fibrin degradation product (FDP)); markers of thrombin generation (thrombin-antithrombin complex (TAT) and soluble fibrin); markers of anticoagulants (protein C (PC) and antithrombin); markers of fibrinolysis (plasminogen, \u03b1\n                      <jats:sub>2<\/jats:sub>\n                      -plasmin inhibitor (PI), plasmin-\u03b1\n                      <jats:sub>2<\/jats:sub>\n                      -PI complex, and plasminogen activator inhibitor (PAI)-1); and a marker of endothelial activation (soluble E-selectin) were assayed. Patients who had overt DIC at baseline were excluded, and the remaining patients were followed for development of overt DIC in 5 days, and for mortality in 28 days.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 77 patients were enrolled, and 37 developed overt DIC within the following 5 days. Most patients demonstrated hemostatic abnormalities at baseline with 98.7% TAT, 97.4% FDP and 88.3% PC. Most hemostatic biomarkers at baseline were significantly associated with subsequent development of overt DIC. Notably, TAT, PAI-1 and PC discriminated well between patients with and without developing overt DIC (area under the receiver operating characteristic curve (AUROC), 0.77 (95% confidence interval, 0.64 to 0.86); 0.87 (0.78 to 0.92); 0.85 (0.76 to 0.91), respectively), and using the three together, significantly improved the AUROC up to 0.95 (vs. TAT, PAI-1, and PC). Among the significant diagnostic markers for overt DIC, TAT and PAI-1 were also good predictors of 28-day mortality (AUROC, 0.77 and 0.81, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Severe coagulation and fibrinolytic abnormalities on ICU admission were associated with subsequent development of overt DIC. A single measurement of TAT, PAI-1, and PC activity could identify patients with ongoing severe coagulopathy, early in the course of sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/cc13190","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T05:06:47Z","timestamp":1389589607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study"],"prefix":"10.1186","volume":"18","author":[{"given":"Kansuke","family":"Koyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Madoiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Nunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitaka","family":"Koinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Mimuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,13]]},"reference":[{"key":"2908_CR1","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/cc2459","volume":"8","author":"GT Kinasewitz","year":"2004","unstructured":"Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF, PROWESS Sepsis Study Group: Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].\n                           Crit Care 2004, 8: R82-R90. 10.1186\/cc2459","journal-title":"Crit Care"},{"key":"2908_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM199908193410807","volume":"341","author":"M Levi","year":"1999","unstructured":"Levi M, Ten Cate H: Disseminated intravascular coagulation.\n                           N Engl J Med 1999, 341: 586-592. 10.1056\/NEJM199908193410807","journal-title":"N Engl J Med"},{"key":"2908_CR3","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1378\/chest.128.4.2864","volume":"128","author":"S Zeerleder","year":"2005","unstructured":"Zeerleder S, Hack CE, Wuillemin WA: Disseminated intravascular coagulation in sepsis.\n                           Chest 2005, 128: 2864-2875. 10.1378\/chest.128.4.2864","journal-title":"Chest"},{"key":"2908_CR4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor Jr","year":"2001","unstructured":"Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.\n                           Thromb Haemost 2001, 86: 1327-1330.","journal-title":"Thromb Haemost"},{"key":"2908_CR5","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1111\/j.1538-7836.2004.00955.x","volume":"2","author":"JF Dhainaut","year":"2004","unstructured":"Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.\n                           J Thromb Haemost 2004, 2: 1924-1933. 10.1111\/j.1538-7836.2004.00955.x","journal-title":"J Thromb Haemost"},{"key":"2908_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.thromres.2009.12.008","volume":"126","author":"D Oh","year":"2010","unstructured":"Oh D, Jang MJ, Lee SJ, Chong SY, Kang MS, Wada H: Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.\n                           Thromb Res 2010, 126: 18-23. 10.1016\/j.thromres.2009.12.008","journal-title":"Thromb Res"},{"key":"2908_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.CCM.0000196832.27501.B2","volume":"34","author":"MW Angstwurm","year":"2006","unstructured":"Angstwurm MW, Dempfle CE, Spannagl M: New disseminated intravascular coagulation score: a useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores.\n                           Crit Care Med 2006, 34: 314-320. quiz 328 10.1097\/01.CCM.0000196832.27501.B2","journal-title":"Crit Care Med"},{"key":"2908_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/01.mbc.0000240916.63521.2e","volume":"17","author":"C Voves","year":"2006","unstructured":"Voves C, Wuillemin WA, Zeerleder S: International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.\n                           Blood Coagul Fibrinolysis 2006, 17: 445-451. 10.1097\/01.mbc.0000240916.63521.2e","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2908_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1159\/000083838","volume":"33","author":"H Ten Cate","year":"2003","unstructured":"Ten Cate H: Trombocytopenia: one of the markers of disseminated intravascular coagulation.\n                           Pathophysiol Haemost Thromb 2003, 33: 413-416. 10.1159\/000083838","journal-title":"Pathophysiol Haemost Thromb"},{"key":"2908_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-9255-10-7","volume":"10","author":"J Song","year":"2013","unstructured":"Song J, Hu D, He C, Wang T, Liu X, Ma L, Lin Z, Chen Z: Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model.\n                           J Inflamm (Lond) 2013, 10: 7. 10.1186\/1476-9255-10-7","journal-title":"J Inflamm (Lond)"},{"key":"2908_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00001721-200501000-00011","volume":"16","author":"CH Toh","year":"2005","unstructured":"Toh CH, Downey C: Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation.\n                           Blood Coagul Fibrinolysis 2005, 16: 69-74. 10.1097\/00001721-200501000-00011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2908_CR12","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","volume":"38","author":"M Levi","year":"2010","unstructured":"Levi M, van der Poll T: Inflammation and coagulation.\n                           Crit Care Med 2010, 38: S26-S34.","journal-title":"Crit Care Med"},{"key":"2908_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.tcam.2012.06.003","volume":"27","author":"M O\u2019Brien","year":"2012","unstructured":"O\u2019Brien M: The reciprocal relationship between inflammation and coagulation.\n                           Top Companion Anim Med 2012, 27: 46-52. 10.1053\/j.tcam.2012.06.003","journal-title":"Top Companion Anim Med"},{"key":"2908_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jcrc.2012.10.069","volume":"28","author":"K Koyama","year":"2013","unstructured":"Koyama K, Madoiwa S, Tanaka S, Koinuma T, Wada M, Sakata A, Ohmori T, Mimuro J, Nunomiya S, Sakata Y: Evaluation of hemostatic biomarker abnormalities that precede platelet count decline in critically ill patients with sepsis.\n                           J Crit Care 2013, 28: 556-563. 10.1016\/j.jcrc.2012.10.069","journal-title":"J Crit Care"},{"issue":"29","key":"2908_CR15","first-page":"530","volume":"2003","author":"MM Levy","year":"2001","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions Conference: SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.\n                           Intensive Care Med 2001,2003(29):530-538.","journal-title":"Intensive Care Med"},{"key":"2908_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system.\n                           Crit Care Med 1985, 13: 818-829. 10.1097\/00003246-198510000-00009","journal-title":"Crit Care Med"},{"key":"2908_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.\n                           Intensive Care Med 1996, 22: 707-710. 10.1007\/BF01709751","journal-title":"Intensive Care Med"},{"key":"2908_CR18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000202209.42491.38","volume":"34","author":"S Gando","year":"2006","unstructured":"Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Murata A, Ikeda T, Ishikura H, Ueyama M, Ogura H, Kushimoto S, Saitoh D, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group: A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria.\n                           Crit Care Med 2006, 34: 625-631.","journal-title":"Crit Care Med"},{"key":"2908_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.\n                           Intensive Care Med 2008, 34: 17-60. Erratum in: Intensive Care Med 2008, 34:783\u2013785 10.1007\/s00134-007-0934-2","journal-title":"Intensive Care Med"},{"key":"2908_CR20","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s00134-004-2291-8","volume":"30","author":"A Amaral","year":"2004","unstructured":"Amaral A, Opal SM, Vincent JL: Coagulation in sepsis.\n                           Intensive Care Med 2004, 30: 1032-1040. 10.1007\/s00134-004-2291-8","journal-title":"Intensive Care Med"},{"key":"2908_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJM200108093450603","volume":"345","author":"SN Faust","year":"2001","unstructured":"Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS: Dysfunction of endothelial protein C activation in severe meningococcal sepsis.\n                           N Engl J Med 2001, 345: 408-416. 10.1056\/NEJM200108093450603","journal-title":"N Engl J Med"},{"key":"2908_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1055\/s-0028-1092876","volume":"34","author":"M Levi","year":"2008","unstructured":"Levi M, van der Poll T: The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients.\n                           Semin Thromb Hemost 2008, 34: 459-468. 10.1055\/s-0028-1092876","journal-title":"Semin Thromb Hemost"},{"key":"2908_CR23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1160\/TH07-02-0117","volume":"98","author":"S Bergmann","year":"2007","unstructured":"Bergmann S, Hammerschmidt S: Fibrinolysis and host response in bacterial infections.\n                           Thromb Haemost 2007, 98: 512-520.","journal-title":"Thromb Haemost"},{"key":"2908_CR24","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1532\/IJH97.05190","volume":"84","author":"S Madoiwa","year":"2006","unstructured":"Madoiwa S, Nunomiya S, Ono T, Shintani Y, Ohmori T, Mimuro J, Sakata Y: Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.\n                           Int J Hematol 2006, 84: 398-405. 10.1532\/IJH97.05190","journal-title":"Int J Hematol"},{"key":"2908_CR25","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1378\/chest.103.5.1536","volume":"103","author":"JA Lorente","year":"1993","unstructured":"Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A: Time course of hemostatic abnormalities in sepsis and its relation to outcome.\n                           Chest 1993, 103: 1536-1542. 10.1378\/chest.103.5.1536","journal-title":"Chest"},{"key":"2908_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00001721-200007000-00006","volume":"11","author":"T Saetre","year":"2000","unstructured":"Saetre T, Lindgaard AK, Lyberg T: Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock.\n                           Blood Coagul Fibrinolysis 2000, 11: 433-438. 10.1097\/00001721-200007000-00006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2908_CR27","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1097\/01.CCM.0000181296.53204.DE","volume":"33","author":"GT Kinasewitz","year":"2005","unstructured":"Kinasewitz GT, Zein JG, Lee GL, Nazir SA, Taylor FB Jr: Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis.\n                           Crit Care Med 2005, 33: 2214-2221. 10.1097\/01.CCM.0000181296.53204.DE","journal-title":"Crit Care Med"},{"key":"2908_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/01.CCM.0000153520.31562.48","volume":"33","author":"JF Dhainaut","year":"2005","unstructured":"Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR: Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.\n                           Crit Care Med 2005, 33: 341-348. 10.1097\/01.CCM.0000153520.31562.48","journal-title":"Crit Care Med"},{"key":"2908_CR29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/01.ta.0000251420.41427.d3","volume":"63","author":"T Iba","year":"2007","unstructured":"Iba T, Gando S, Murata A, Kushimoto S, Saitoh D, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, Mayumi T, Ikeda T, Ishhikura H, Ueyama M, Ogura Y, Endo S, Shimazaki S, Japanese Association for Acute Medicine Disseminated Intravascular Coagulation Study Group: Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.\n                           J Trauma 2007, 63: 1093-1098. 10.1097\/01.ta.0000251420.41427.d3","journal-title":"J Trauma"},{"key":"2908_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.shk.0000144422.32647.b6","volume":"23","author":"T Iba","year":"2005","unstructured":"Iba T, Kidokoro A, Fukunaga M, Sugiyama K, Sawada T, Kato H: Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers.\n                           Shock 2005, 23: 25-29. 10.1097\/01.shk.0000144422.32647.b6","journal-title":"Shock"},{"key":"2908_CR31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1160\/TH08-07-0448","volume":"101","author":"M Egi","year":"2009","unstructured":"Egi M, Morimatsu H, Wiedermann CJ, Tani M, Kanazawa T, Suzuki S, Matsusaki T, Shimizu K, Toda Y, Iwasaki T, Morita K: Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.\n                           Thromb Haemost 2009, 101: 696-705.","journal-title":"Thromb Haemost"},{"key":"2908_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1538-7836.2005.01697.x","volume":"4","author":"J Kienast","year":"2006","unstructured":"Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM, KyberSept Investigators: Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.\n                           J Thromb Haemost 2006, 4: 90-97.","journal-title":"J Thromb Haemost"},{"key":"2908_CR33","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00134-001-1139-8","volume":"27","author":"AC Mavrommatis","year":"2001","unstructured":"Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG: Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.\n                           Intensive Care Med 2001, 27: 1853-1859. 10.1007\/s00134-001-1139-8","journal-title":"Intensive Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc13190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc13190\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc13190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:53:59Z","timestamp":1728370439000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc13190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,2]]}},"alternative-id":["2908"],"URL":"https:\/\/doi.org\/10.1186\/cc13190","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,13]]},"assertion":[{"value":"30 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R13"}}